Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1558

1.

Interferon-free therapy with direct acting antivirals for HCV/HIV-1 co-infected Japanese patients with inherited bleeding disorders.

Uemura H, Tsukada K, Mizushima D, Aoki T, Watanabe K, Kinai E, Teruya K, Gatanaga H, Kikuchi Y, Sugiyama M, Mizokami M, Oka S.

PLoS One. 2017 Oct 18;12(10):e0186255. doi: 10.1371/journal.pone.0186255. eCollection 2017.

PMID:
29045448
2.

Hepatitis in AIDS patients.

Qadir MI.

Rev Med Virol. 2017 Oct 13. doi: 10.1002/rmv.1956. [Epub ahead of print] Review.

PMID:
29027728
3.

Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in Europe.

Marshall AD, Cunningham EB, Nielsen S, Aghemo A, Alho H, Backmund M, Bruggmann P, Dalgard O, Seguin-Devaux C, Flisiak R, Foster GR, Gheorghe L, Goldberg D, Goulis I, Hickman M, Hoffmann P, Jancorienė L, Jarcuska P, Kåberg M, Kostrikis LG, Makara M, Maimets M, Marinho RT, Matičič M, Norris S, Ólafsson S, Øvrehus A, Pawlotsky JM, Pocock J, Robaeys G, Roncero C, Simonova M, Sperl J, Tait M, Tolmane I, Tomaselli S, van der Valk M, Vince A, Dore GJ, Lazarus JV, Grebely J; International Network on Hepatitis in Substance Users (INHSU).

Lancet Gastroenterol Hepatol. 2017 Oct 3. pii: S2468-1253(17)30284-4. doi: 10.1016/S2468-1253(17)30284-4. [Epub ahead of print]

PMID:
28986139
4.

Generic Direct Acting Antivirals in Treatment of Chronic Hepatitis C Infection in Patients of Thalassemia Major.

Nagral A, Sawant S, Nagral N, Parikh P, Malde P, Merchant R.

J Clin Exp Hepatol. 2017 Sep;7(3):172-178. doi: 10.1016/j.jceh.2017.08.002. Epub 2017 Aug 23.

PMID:
28970702
5.

Safety and Efficacy of Ombitasvir, Paritaprevir With Ritonavir ± Dasabuvir With or Without Ribavirin in Patients With Human Immunodeficiency Virus-1 and Hepatitis C Virus Genotype 1 or Genotype 4 Coinfection: TURQUOISE-I Part 2.

Rockstroh JK, Orkin C, Viani RM, Wyles D, Luetkemeyer AF, Lazzarin A, Soto-Malave R, Nelson MR, Bhagani SR, Klinker HHF, Rizzardini G, Girard PM, Tural C, Shulman NS, Mobashery N, Hu YB, Fredrick LM, Pilot-Matias T, Trinh R, Gane E.

Open Forum Infect Dis. 2017 Jul 22;4(3):ofx154. doi: 10.1093/ofid/ofx154. eCollection 2017 Summer.

6.

Elbasvir-grazoprevir: A new direct-acting antiviral combination for hepatitis C.

Karaoui LR, Mansour H, Chahine EB.

Am J Health Syst Pharm. 2017 Oct 1;74(19):1533-1540. doi: 10.2146/ajhp160558. Review.

PMID:
28947524
7.

Validation of a questionnaire to monitor symptoms in HIV-infected patients during hepatitis C treatment.

Cachay ER, Ballard C, Colwell B, Torriani F, Hicks C, Mathews WC.

AIDS Res Ther. 2017 Sep 20;14(1):56. doi: 10.1186/s12981-017-0182-7.

8.

Hepatic steatosis in HCV-infected persons in the direct-acting antiviral era.

Stevenson HL, Utay NS.

Trop Dis Travel Med Vaccines. 2016 Sep 27;2:21. doi: 10.1186/s40794-016-0038-5. eCollection 2016. Review.

9.

Analysis of Hepatitis C Virus NS5A Region in Patients with Cirrhosis Using an Ultra-Deep Pyrosequencing Method.

Keskin F, Ciftci S, Akyuz F, Abaci N, Cakiris A, Akyuz U, Demir K, Besisik F, Ustek D, Kaymakoglu S.

Clin Lab. 2017 Sep 1;63(9):1439-1445. doi: 10.7754/Clin.Lab.2017.170312.

PMID:
28879707
10.

Sofosbuvir-based Regimens in HIV/HCV Coinfected Patients after Liver Transplantation: Results from the ANRS CO23 CUPILT Study.

Antonini TM, Coilly A, Rossignol E, Fougerou-Leurent C, Dumortier J, Leroy V, Veislinger A, Radenne S, Botta-Fridlund D, Durand F, Houssel-Debry P, Kamar N, Canva V, Perré P, De Ledinghen V, Rohel A, Diallo A, Taburet AM, Samuel D, Pageaux GP, Duclos-Vallée JC; ANRS C023 CUPILT study group.

Transplantation. 2017 Aug 24. doi: 10.1097/TP.0000000000001928. [Epub ahead of print]

PMID:
28846559
12.

Real-world effectiveness of sofosbuvir-based treatment regimens for chronic hepatitis C genotype 3 infection: results from the multicenter German hepatitis C cohort (GECCO-03).

Wehmeyer MH, Ingiliz P, Christensen S, Hueppe D, Lutz T, Simon KG, Schewe K, Boesecke C, Baumgarten A, Busch H, Rockstroh J, Schmutz G, Kimhofer T, Berger F, Mauss S, Wiesch JSZ.

J Med Virol. 2017 Jul 15. doi: 10.1002/jmv.24903. [Epub ahead of print]

PMID:
28710853
13.

HCV antigen instead of RNA testing to diagnose acute HCV in patients treated in the Dutch Acute HCV in HIV Study.

Hullegie SJ, GeurtsvanKessel CH, van der Eijk AA, Ramakers C, Rijnders BJA.

J Int AIDS Soc. 2017 Jun 30;20(1):21621. doi: 10.7448/IAS.20.1.21621.

14.

Sofosbuvir-velpatasvir: A single-tablet treatment for hepatitis C infection of all genotypes.

Miller MM.

Am J Health Syst Pharm. 2017 Jul 15;74(14):1045-1052. doi: 10.2146/ajhp60632. Review.

PMID:
28687550
15.

Effectiveness and safety of first-generation protease inhibitors in real-world patients with hepatitis C virus genotype 1 infection in Brazil: a multicenter study.

Callefi LA, Villela-Nogueira CA, de Barros Tenore S, Carnaúba-Júnior D, Coelho HSM, Pinto PTA, Nabuco LC, Pessoa MG, Ferraz MLCG, Ferreira PRA, de Lourdes Candolo Martinelli A, Chachá SGF, de Souza Paiva Ferreira A, de Macedo Bisio AP, Brandão-Mello CE, Álvares-Da-Silva MR, Reuter T, Ivantes CAP, de Mello Perez R, Mendes-Correa MCJ.

Clinics (Sao Paulo). 2017 Jun;72(6):378-385. doi: 10.6061/clinics/2017(06)08.

16.

Origin, prevalence and response to therapy of hepatitis C virus genotype 2k/1b chimeras.

Susser S, Dietz J, Schlevogt B, Zuckerman E, Barak M, Piazzolla V, Howe A, Hinrichsen H, Passmann S, Daniel R, Cornberg M, Mangia A, Zeuzem S, Sarrazin C.

J Hepatol. 2017 Oct;67(4):680-686. doi: 10.1016/j.jhep.2017.05.027. Epub 2017 Jun 13.

PMID:
28619439
17.

High hepatitis C cure rates among black and nonblack human immunodeficiency virus-infected adults in an urban center.

Falade-Nwulia O, Sutcliffe C, Moon J, Chander G, Wansom T, Keruly J, Katzianer J, Nathanson A, Marks J, Mehta S, Thomas D, Moore R, Sulkowski M.

Hepatology. 2017 Jun 13. doi: 10.1002/hep.29308. [Epub ahead of print]

PMID:
28608973
18.

Cost per care of the first year of direct antiviral agents in the Liguria Region: a multicenter analysis.

Cenderello G, Fanizza C, Marenco S, Nicolini LA, Artioli S, Baldissarro I, Dentone C, De Leo P, Di Biagio A.

Clinicoecon Outcomes Res. 2017 May 22;9:281-293. doi: 10.2147/CEOR.S129859. eCollection 2017.

19.

Highly Successful Hepatitis C Virus (HCV) Treatment Outcomes in Human Immunodeficiency Virus/HCV-Coinfected Patients at a Large, Urban, Ryan White Clinic.

Patel M, Rab S, Kalapila AG, Kyle A, Okosun IS, Miller L.

Open Forum Infect Dis. 2017 Apr 5;4(2):ofx062. doi: 10.1093/ofid/ofx062. eCollection 2017 Spring.

20.

Patient-reported outcomes in patients co-infected with hepatitis C virus and human immunodeficiency virus treated with sofosbuvir and velpatasvir: The ASTRAL-5 study.

Younossi ZM, Stepanova M, Sulkowski M, Wyles D, Kottilil S, Hunt S.

Liver Int. 2017 May 4. doi: 10.1111/liv.13462. [Epub ahead of print]

PMID:
28470938

Supplemental Content

Loading ...
Support Center